Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation

Background/Objectives: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of various malignancies, but their use is frequently accompanied by immune-related adverse events, among which immune-mediated colitis (IMC) represents one of the most common and clinically significant gastr...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Zeljka Belosic Halle, Vedran Tomasic, Alen Biscanin, Petra Cacic, Ivona Saric, Sanda Mustapic, Josip Stojic, Kresimir Luetic, Dinko Bekic, Matej Paic, Domagoj Micetic, Irena Krznaric Zrnic, Ivna Olic, Melanija Razov Radas, Iva Skocilic, Marin Golčic, Laura Rados, Jasna Radic, Juraj Prejac, Ivana Mikolasevic
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2026-03-01
Rangatū:	Biomedicines
Ngā marau:	immune checkpoint inhibitors colitis immunotherapy immune-mediated colitis microbiota fecal microbiota transplantation
Urunga tuihono:	https://www.mdpi.com/2227-9059/14/3/683
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!